life sciences

8+ articles

AI AI credits AI in healthcare AI models Anthropic

Takeda Pharmaceuticals Announces Major Layoffs in Massachusetts: Impacting Local Biotech Scene

Takeda Pharmaceuticals is set to lay off 400 employees at their U.S. headquarters in Cambridge, Massachusetts, as part of a broader effort to streamline operations and focus on high-potential therapies. This move, aimed at simplifying organizational structures, will heavily impact the local biotech community in Kendall Square, renowned as a global epicenter for biotech innovation.

Apr 4

Takeda Pharmaceuticals Announces Major Layoffs in Massachusetts: Impacting Local Biotech Scene

Anthropic Goes Big on Biotech: Snags Coefficient Bio for a Cool $400 Million!

In a strategic move that underscores the intersection of AI and biotechnology, Anthropic has acquired Coefficient Bio, an AI biotech startup, for approximately $400 million. This significant acquisition bolsters Anthropic's efforts to integrate artificial intelligence solutions into the biotech sector, particularly in drug discovery and life sciences applications.

Apr 3

Anthropic Goes Big on Biotech: Snags Coefficient Bio for a Cool $400 Million!

Anthropic's Bold Move: Acquiring Stealth AI Innovator Coefficient Bio for $400M

Anthropic, the trailblazer in AI, has expanded its horizons by acquiring Coefficient Bio—a stealth startup backed by Dimension— for over $400 million. Known for developing cutting-edge AI models for biological research, Coefficient Bio is set to enhance Anthropic's capabilities in the life sciences sector.

Apr 3

Anthropic's Bold Move: Acquiring Stealth AI Innovator Coefficient Bio for $400M

Anthropic's Claude Supercharges Genetic Research with AI Credits Initiative

In a groundbreaking move, Anthropic launches its "AI for Science" program, offering researchers in genomics and drug discovery up to $20,000 in API credits for their Claude AI model. This initiative aims to enhance data analysis and accelerate scientific advancements while ensuring ethical guidelines through a required biosecurity assessment.

May 7

Anthropic's Claude Supercharges Genetic Research with AI Credits Initiative

Anthropic Unveils 'AI for Science' Initiative with $20K in API Credits

Anthropic has announced its 'AI for Science' program, offering up to $20,000 in API credits to researchers. This initiative focuses on utilizing AI models, particularly in biology and life sciences, to enhance data analysis, hypothesis generation, and experiment design. With a required biosecurity assessment, the program aims to ensure responsible AI use in cutting-edge scientific research.

May 7

Anthropic Unveils 'AI for Science' Initiative with $20K in API Credits

Inside Isomorphic Labs: Google's AI-Powered Revolution in Life Sciences

Explore how Isomorphic Labs, a spinoff from Google DeepMind, is leveraging cutting-edge AI technologies to revolutionize the field of life sciences. With promising advancements in drug discovery and biology, this venture is set to change the game for medical research and treatment.

Apr 9

Inside Isomorphic Labs: Google's AI-Powered Revolution in Life Sciences

Cytiva Unveils Workforce Cuts: 85 Job Losses at Westborough Facility Amid Biopharma Restructuring

Cytiva, a leader in life sciences owned by Danaher Corporation, will lay off 85 employees starting March 7, 2025, at its Westborough, MA facility to ensure long-term success. The job cuts align with a broader restructuring trend in the biopharma sector, with the specific roles affected yet to be disclosed. Cytiva focuses on bioprocessing, cell and gene therapy, and diagnostics.

Mar 4

Cytiva Unveils Workforce Cuts: 85 Job Losses at Westborough Facility Amid Biopharma Restructuring

Utah's Booming Biotech: From Small Fry to $22 Billion Powerhouse

Utah's biotech industry has transformed into a $22 billion titan, offering 50,000 jobs with salaries 50% above the state average. Specializing in cutting-edge life sciences, the state is advancing aortic valve replacements, cancer treatments, and brain-computer interfaces. While enjoying a growth rate surpassing national averages, Utah attracts fresh talent and ventures but faces challenges in diversity and regulatory oversight. With ambitious growth on the horizon, Utah is set to give Boston and San Francisco a run for their money in the biotech arena.

Jan 26

Utah's Booming Biotech: From Small Fry to $22 Billion Powerhouse